ZNRF3 and adrenal cortex carcinoma: Thus, activation of the Wnt/beta-catenin pathway triggered by CTNNB1 and ZNRF3 mutations or down regulation of Wnt/beta-catenin inhibitors are important for ACC pathogenesis.